OQS
GNLX icon

Occudo Quantitative Strategies’s Genelux GNLX Stock Holding History

Occudo Quantitative Strategies’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,549
Closed -$80.7K – 844
2024
Q1 		$80.7K Buy
+12,549
New +$114K 0.01% 670

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PWM
Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Occudo Quantitative Strategies's GNLX Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of Genelux (GNLX) in Q2 2024, closing a stake of 12,549 shares — an estimated $80.7K sold.

Occudo Quantitative Strategies first reported a position in GNLX in Q1 2024 and held it in 1 quarter. The position peaked at $80.7K in Q1 2024. 73 funds tracked by Wall St. Rank hold GNLX as of Q2 2024.

  • Occudo Quantitative Strategies reported no remaining Genelux position as of Q2 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 12,549 Genelux shares in Q2 2024, an estimated $80.7K.
  • Occudo Quantitative Strategies first reported a position in Genelux in Q1 2024 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Genelux position peaked at $80.7K in Q1 2024.
  • 73 funds tracked by Wall St. Rank held Genelux as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.